NEWS / BLOG
Gentronix News and Blog section gives you our latest company updates, comments on the field of toxicology and insights into our business, values and commitment to our clients.
LATEST NEWS
Join Gentronix at the SOT 2021 Virtual Event
The Society of Toxicology annual meeting is always the first conference on our schedule to attend and it is an event that Gentronix has exhibited at for over 15 consecutive years. It’s [...]
Gentronix expands services to meet growing global demand
UK-based Contract Research Organisation (CRO) Gentronix – a specialist toxicology CRO based at Alderley Park – is expanding its service range to provide new, specialist services in the [...]
Gentronix Strengthens Executive Team to Support Continued Growth
UK-based Contract Research Organisation (CRO) Gentronix – the largest independent genetic toxicology CRO in Europe - has appointed a new Operations Director to accelerate its strategic [...]
BLOG
Benefits of a combination of 24-well Ames and 96-well MNT assays
Importance of Genetic Toxicology Including genetic toxicology in the early drug discovery phase is a key step in improving the safety profile of the chemical series under development a [...]
A brief introduction to the KeratinoSens™ assay
Key Event 2 (KE2) in AOP. The second key event in the skin sensitisation AOP considers whether a single chemical, formulation, or mixture can activate keratinocytes and the associated [...]
Using the DPRA assay to generate GLP study data
Key Event 1 (KE!) in AOP. Within the skin sensitisation adverse outcome pathway, the first key event is based on the premise that a chemical can become a skin sensitiser via interactio [...]
OUR VALUES
OUR VALUES
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
Our business origins are in the delivery of innovative screening products for toxicological hazard; challenging the established approach with scientific rigour. Building on our experiences of developing market leading predictive toxicology assays, we have extended our expertise to the regulatory tests for genetic toxicology and recently skin sensitisation.
We make a commitment to our clients to perform toxicology studies of the highest scientific quality; not merely to produce data, but to deliver the most appropriate data endpoints, using the right assay tools, guided by scientific engagement and experience. Furthermore, we are committed to helping our clients understand and interpret their results, supporting navigation of regulatory landscapes and management of adverse toxicology findings.
This is guided by our core values, which we apply to all the studies we perform:
LATEST VACANCIES
At Gentronix, we have a passion for the science of toxicology. Building on our experience gained from the pharmaceutical, agrochemical and CRO industries, we are committed to engaging with our clients to deliver the highest quality to science to support their projects. If believe you have the toxicology knowledge and the interest to support us in delivering this commitment, we’re interested to learn more.